Profusol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profusol

This section provides a factual overview of the drug Profusol, focusing solely on its core identity, composition, and general purpose, strictly avoiding clinical instructions, specific uses, or safety information.

Property Description
Active Ingredient Ibuprofen
Form Oral (Tablet, Capsule, Suspension), Topical (Gel), Parenteral
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Purpose Pain Relief (Analgesia), Fever Reduction (Antipyresis), Inflammation Management
Origin Synthetic, Propionic acid derivative

What Type of Medicine is Profusol?

Profusol is a trade name for a medicinal product containing the active component Ibuprofen, which belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) class. This classification confirms that the drug addresses three distinct physiological responses: pain, fever, and inflammation. Profusol is often positioned for the management of everyday discomforts, such as the aches and pains associated with conditions like the common cold.

Ibuprofen is a synthetic propionic acid derivative developed in a laboratory. Its placement in the NSAID class means that it functions through a specific, non-narcotic mechanism to achieve analgesia (pain relief) and antipyresis (fever reduction), without containing corticosteroids or opiate compounds. The core function of Profusol is to provide comprehensive relief for general aches and symptoms by modifying the body's inflammatory and temperature responses.


Profusol's Composition and Forms

The single active ingredient in Profusol is Ibuprofen. This compound is manufactured as a racemic mixture, meaning it contains two mirror-image molecular forms, with one primarily responsible for the therapeutic effects. The active ingredient is rapidly absorbed following oral administration.

Profusol is made available in several distinct dosage forms to accommodate various routes of administration. These forms include common oral formulations, such as tablets, capsules, and oral suspensions (liquid), which allow for systemic absorption. Additionally, it may be found in topical formulations like gels, or specialized parenteral (injectable) preparations used in clinical settings.


General Therapeutic Purpose of Profusol

The primary therapeutic purpose of Profusol is to provide combined pain relief, fever reduction, and manage inflammation. Profusol achieves these general benefits by acting as a Cyclooxygenase (COX) inhibitor, a mechanism that temporarily interrupts the production of prostaglandins, the chemical mediators that promote these symptoms. By diminishing the concentration of these specific chemical messengers, Profusol effectively lessens the underlying physical responses that contribute to discomfort.

Regulatory References

  1. Ibuprofen on WHO Essential Medicines List
  2. Ibuprofen Drug Information (Mechanism of Action)

What side effects are possible with Profusol?

Possible Side Effects and Safety Information

Official regulatory documents emphasize that Profusol is associated with the risk of serious side effects, primarily affecting the cardiovascular and gastrointestinal systems.

Serious Risks

Regulatory agencies have issued a serious warning regarding an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may increase with longer duration of use and higher doses. Profusol is also linked to serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal.

Adverse Reactions

Adverse reactions documented in official labeling include effects across multiple System Organ Classes:

  • Gastrointestinal: Common events include abdominal pain, nausea, heartburn, diarrhea, and constipation. Serious, but less common, events include gastric/duodenal ulceration and hemorrhage.
  • Central Nervous System: Headache, dizziness, and nervousness are commonly reported.
  • Dermatologic: Rashes and pruritus (itching) are known. Rare, but severe, reactions such as Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis have been documented.
  • Other: Hypersensitivity reactions (including anaphylaxis) and potential for fluid retention and edema are also noted.

Safety Considerations

Specific warnings highlight certain populations and circumstances that increase risk:

  • High-Risk Groups: Elderly patients (aged 60 and older) and individuals with a prior history of gastrointestinal disease are at a higher risk of serious GI events.
  • Contraindications: Profusol is contraindicated for the treatment of pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and is contraindicated in the late stages of pregnancy (third trimester).

Overdose and Emergency Response

Overdose and when to seek help for Profusol

An overdose of Profusol, the brand name for Ibuprofen, is officially documented as potentially presenting with gastrointestinal distress, including nausea, vomiting, and abdominal pain. Initial Central Nervous System (CNS) effects such as drowsiness, confusion, severe headache, or ringing in the ears (tinnitus) are also recognized manifestations of toxicity listed in regulatory prescribing information.

The official profile emphasizes that overdose can rapidly lead to severe, life-threatening systemic toxicity. Documented critical outcomes include seizures, coma, acute renal failure (little to no urine output), hypotension (low blood pressure), and severe gastrointestinal bleeding or perforation, which may be fatal. Regulatory documents note that elderly patients face an increased risk of severe gastrointestinal events.

Because no specific antidote is known, the mandatory regulatory requirement is to seek immediate medical attention upon known or suspected overdose. Individuals must contact a poison control center right away and not delay calling for help. Management is defined as symptomatic and supportive, often requiring interventions like activated charcoal and continuous cardiac and renal monitoring in a hospital setting.

Therapeutic Uses of Profusol

What Profusol Treats: Main Uses and Benefits

Profusol (Ibuprofen) is a common, symptom-focused medication relevant in contexts where short-term symptomatic assistance is appropriate, helping to address groups of symptoms that may appear suddenly or fluctuate. Its use centers on easing physical discomfort, reducing fever, and managing minor aches and pains. The key therapeutic benefit contributes to easing the overall symptom load, helping patients cope more steadily with difficult episodes.


Acute Pain, Headaches, and Cyclical Discomfort

Profusol may be applied in clinical settings that involve episodic pain management for symptoms related to physical discomfort. It is relevant for managing symptoms associated with acute manifestations, such as tension headaches, post-dental pain, and the recurrent, disruptive symptoms of primary dysmenorrhea (menstrual cramps). It supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.


Musculoskeletal and Inflammatory Symptom Control

This medication is used in situations involving certain distressing symptoms related to inflammatory or irritative states, where the goal is to ease the combined symptoms of inflammation, swelling, stiffness, and associated pain. It is commonly used across conditions presenting with inflammatory or irritative processes, and may assist with the symptomatic support of chronic conditions, such as rheumatoid arthritis and osteoarthritis, characterized by periods of heightened symptoms.


Fever and Systemic Aches

Profusol is applied in contexts involving heightened systemic burden where short-term symptom stabilization is important to moderate manifestations like fever and generalized body aches. It is relevant in conditions presenting with systemic discomfort and helps address symptom clusters associated with illnesses like the common cold and influenza, contributing to improved day-to-day comfort during symptomatic periods.


Quick Fact: Supports management of Inflammation and Pain

Eligibility and Restrictions for Use

Who Can and Cannot Use Profusol?

Profusol (Ibuprofen) eligibility is defined by official regulatory documents based on patient status, age, and pre-existing conditions. These classifications establish groups who are permitted, restricted, or strictly contraindicated from using the medicine.

Absolute Contraindications

Profusol is strictly prohibited for patients with a known hypersensitivity to ibuprofen, aspirin, or other NSAIDs, including those with a history of NSAID-sensitive asthma. It must not be used by patients with active gastrointestinal bleeding or recurrent peptic ulceration. Use is also contraindicated for patients with severe heart, renal, or hepatic failure, and for the treatment of pain following coronary artery bypass graft (CABG) surgery.

Age and Conditional Use

Population Eligibility Status (Regulatory Wording)
Pediatric Use Generally permitted for children over six months of age, but specific oral forms may be restricted for children under 20 kg body weight.
Third Trimester Pregnancy Contraindicated (Prohibited).
Older Adults Use requires particular caution due to increased risk of serious gastrointestinal and renal events.

Eligibility is conditional for individuals with mild-to-moderate organ impairment, uncontrolled hypertension, or established cardiovascular disease. For these groups, use is restricted to the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the formal interaction patterns and restrictions for Profusol (Ibuprofen) as officially documented by government regulatory bodies.


Formal Contraindicated Combinations

Profusol is contraindicated (prohibited) for co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and with high-dose Acetylsalicylic Acid (Aspirin) (above 75 mg daily). These combinations are restricted due to an officially documented increased risk of serious gastrointestinal events like bleeding and ulceration. Furthermore, Profusol is prohibited for treating pain immediately before or after Coronary Artery Bypass Graft (CABG) surgery.


Pharmacodynamic and Exposure-Altering Interactions

Co-administered Substance Official Interaction Outcome Regulatory Note
Anticoagulants (e.g., Warfarin) Increased risk of severe bleeding. Potentiation of anticoagulant effects.
Lithium and Methotrexate Increased plasma levels. Profusol reduces renal clearance, increasing potential toxicity risk.
SSRI Antidepressants Increased risk of gastrointestinal bleeding. Documented additive risk.
Diuretics / ACE/ARBs Diminished antihypertensive/diuretic effect. Increased risk of combined nephrotoxicity.

Timing and Substance Interactions

If taken with cardioprotective low-dose Aspirin, Profusol must be administered at least 8 hours before or 30 minutes after the Aspirin dose to prevent interference with its anti-platelet effect. Concomitant use with alcohol is officially documented to increase the risk of stomach bleeding.

Interaction risk is noted as being compounded and more severe for elderly patients and those with existing impaired renal function.

Mechanism of Action

Profusol's Mechanism of Action

Profusol exerts its primary action as an inhibitor by binding to and blocking the active site of Cyclooxygenase (COX) enzymes. This interaction effectively halts the conversion of arachidonic acid into prostaglandins and other eicosanoids, thereby modulating the Prostaglandin Synthesis Pathway. The reduced concentration of these lipid mediators influences signaling dynamics across multiple systems. Peripherally, this mechanism diminishes the sensitization of nerve endings and affects localized vascular responses.

Centrally, the reduction of prostaglandin activity, specifically within the hypothalamus (the brain's thermoregulatory system), influences the temperature control set-point. This systemic physiological consequence promotes the resetting of an elevated hypothalamic temperature set-point toward the homeostatic range, engaging the body's natural heat-loss mechanisms (including sweating and peripheral vasodilation), which results in an alteration of central thermoregulation.

Dosage and Administration Information

How Profusol is Used: Official Administration Guidelines

This section details the administration and dosing principles for Profusol (Ibuprofen), providing information solely on how the medication is used.


Administration Routes and Forms

Profusol is approved for two primary routes of administration: Oral (tablets, capsules, and oral suspensions, such as 200 mg or 400 mg strengths) and Intravenous (IV). The IV route, involving a solution for infusion, is reserved for supervised clinical settings when oral administration is impractical.

Standard Dosing and Frequency

Standard limits define the parameters for use. For acute conditions, the typical oral dose is 200 mg to 400 mg taken every 4 to 6 hours as needed. The lowest effective dose should be used for the shortest duration necessary for symptom control, with a maximum daily limit of 3200 mg.


Contextual and Population-Specific Rules

Usage Instruction Domain Official Requirement (Label-Based)
Timing in Relation to Meals Recommended to be taken with food or milk to reduce the potential for gastrointestinal irritation.
Acute Duration Limit For non-prescription use, do not take for more than 10 days for pain or 3 days for fever without professional guidance.
IV Administration Must be administered as an infusion over a specified time, such as at least 30 minutes in the clinical setting.
Older Adults/Impairment Requires the use of the lowest effective dose for the shortest time, with monitoring for those with reduced renal or hepatic function.

These guidelines establish the structure for using the medicine by dictating the form, dose, and frequency, ensuring consistency with established usage parameters.

Recent Clinical Evidence

Research evidence / Overview of studies for Profusol

Evidence for Use in Acute Pain and Cyclical Discomfort

Research has examined Profusol's active component in contexts involving sudden, mild-to-moderate physical discomfort and menstrual cramps, utilizing Randomized Controlled Trials and meta-analyses. Studies explored patient-reported outcomes describing perceived discomfort, such such as a measured change in pain scale scores. Studies contribute to the broader evidence landscape related to physical discomfort. The research provides limited insight into pain that persists beyond the acute, initial 48-hour observation period in research settings.


Evidence for Use in Fever Reduction (Antipyresis)

Rigorous research, primarily comparative trials, has investigated how symptoms evolve related to elevated body temperature in both adult and pediatric populations. Studies monitored outcomes related to systemic imbalance by measuring temperature reduction. Findings describe outcomes capturing phases of heightened symptom activity. Research literature notes ongoing scientific discussion regarding optimal dosing strategies for certain pediatric subgroups, and there is limited information for long-term outcomes concerning repeated use.


Evidence for Use in Musculoskeletal and Chronic Symptom Control

The active component was evaluated in conditions characterized by functional limitations, such as Osteoarthritis and Rheumatoid Arthritis. Research examined long-term controlled trials, monitoring outcomes like joint stiffness and physical function scores over observation periods of several weeks to one year. Studies contribute to the broader evidence landscape related to daily functioning. The body of research is heterogeneous, and evidence is limited concerning long-term effects on the underlying condition.


Long-Term Studies and Durability of Symptomatic Response

Research was studied for sustained use of the active ingredient in conditions involving periods of heightened symptoms, monitoring patient-reported outcomes over defined time intervals, sometimes spanning months. Follow-up durations were limited in some studies. The certainty remains low regarding outcomes of use spanning many years.


Evidence in Special Patient Populations

Profusol’s active component was observed in studies involving specific subgroups, including older adults and children. These studies examined how symptoms evolved in the observed populations, and outcomes related to systemic imbalance were monitored. Data for certain groups remain insufficient, and evidence quality varies across studies, particularly for individuals with certain pre-existing comorbid conditions.


What is Still Uncertain About Profusol's Research Base

A major limitation is that there is limited information for long-term outcomes, as follow-up durations were limited across many trials. Comparative evidence is lacking for certain administration methods or for patients with several comorbid conditions, meaning results apply primarily to the populations studied. Furthermore, evidence quality varies across studies, indicating that findings were mixed across the broader research landscape.

Key Studies & References Ibuprofen: Mechanism of Action (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Profusol (FAQ)

Q: Can I take over-the-counter pain relievers or cold medicines with Profusol?

A: Official warnings prohibit co-administration with other NSAIDs (Nonsteroidal Anti-inflammatory Drugs) and high-dose Aspirin due to the risk of serious stomach bleeding.

The labeling does not list a specific prohibition against all non-NSAID over-the-counter pain or cold products, though warnings regarding gastrointestinal risk apply.

Q: Can elderly patients use Profusol safely, according to regulatory information?

A: Official regulatory documents state that the use of Profusol in older adults (aged 60 and older) requires particular caution.

This is because this population is documented to have an increased risk of serious gastrointestinal bleeding and kidney-related adverse events. Official documentation indicates that monitoring is required for those with reduced organ function.

Q: Does Profusol affect blood sugar levels?

A: The official regulatory information for Profusol does not list a standard warning or caution regarding its effect on blood sugar levels.

Routine monitoring of blood glucose is typically not mandated for the general population according to official labeling.

Q: Is it common to feel a slight headache or nausea when starting Profusol?

A: Headache and nausea are two of the effects documented in official adverse reaction lists.

According to regulatory data, these effects are classified as commonly reported following the use of Profusol.

Q: Can Profusol be crushed or split for easier swallowing?

A: Official administration guidelines detail the use of approved oral forms, such as tablets, capsules, and suspensions.

However, the product labeling does not contain instructions authorizing the tablets or capsules to be crushed or split.

Q: Is Profusol safe for people with heart conditions?

A: Profusol is contraindicated (prohibited) for patients who have severe heart failure and for managing pain after Coronary Artery Bypass Graft (CABG) surgery.

Regulatory agencies have also issued a serious warning that use of Profusol may increase the risk of cardiovascular events, including heart attack and stroke.

Q: Does Profusol cause weight gain or weight loss?

A: Official adverse reaction lists document the potential for fluid retention and edema (swelling) associated with Profusol use.

Fluid retention and edema are documented adverse effects associated with Profusol use.

Q: Does Profusol interact with herbal supplements like St. John's Wort or melatonin?

A: Official regulatory documents do not specifically list St. John’s Wort or melatonin.

However, general warnings apply to co-administration with any substances that may increase the overall risk of gastrointestinal bleeding when combined with Profusol.

Q: How long does it typically take for Profusol to start working or show noticeable effects?

A: Official pharmacokinetic data describes the rate at which the active component is absorbed by the body.

Following oral administration, the substance is typically absorbed quickly, with peak concentrations reached in the blood within one to two hours.

Q: How will I know if Profusol is having an effect?

A: The expected therapeutic effect corresponds to a reduction in the symptoms Profusol is intended to address.

This includes a decrease in pain, a lowering of elevated body temperature (fever), and management of localized inflammation.

Q: Is Profusol approved for use in children and adolescents?

A: According to regulatory documents, the medicine is generally permitted for children over six months of age.

However, specific liquid or oral forms may be restricted based on a child's body weight, such as those under 20 kg.

Q: I heard Profusol is a controlled substance—is that true?

A: Profusol is a trade name for a medication classified by regulatory authorities as a Nonsteroidal Anti-inflammatory Drug (NSAID).

It is not listed as a controlled substance and does not contain any opiate compounds.

Q: Will Profusol impact my fertility?

A: Regulatory warnings note that, similar to other drugs that inhibit prostaglandin synthesis, caution is warranted for women who are actively trying to conceive.

This is based on evidence suggesting the active ingredient may potentially impair female fertility.

Q: Does taking Profusol affect my ability to donate blood?

A: Profusol acts as an anti-platelet agent, which is a key factor in blood donation.

Blood donation guidelines reference a typical 48-hour waiting period after using Profusol for platelet donation, but generally permit donation of whole blood.

Q: What is the difference between the brand name and the generic version of Profusol?

A: Regulatory requirements ensure that the generic version is mandated to contain the identical active ingredient (Ibuprofen).

Furthermore, the generic must be bioequivalent to the brand name, meaning it must achieve the same strength, quality, and therapeutic effect in the body.

Q: Is Profusol approved by international agencies like the EMA?

A: The active component in Profusol is an established medicinal product that is approved and regulated by multiple global health authorities.

These include organizations such as the European Medicines Agency (EMA) and the UK's MHRA.

Q: Are there any monitoring requirements (like lab tests) while on Profusol?

A: While not every patient requires constant monitoring, Official documentation indicates that monitoring is required for patients with existing impaired renal or hepatic function (kidney or liver problems).

This is due to the increased risk of adverse events affecting these systems.

Q: Why do some people experience a metallic taste with Profusol? (Specific side effect curiosity)

A: Although not a commonly listed adverse event, the active component of Profusol is known to be associated with taste disturbances, also called dysgeusia.

This may sometimes be described as experiencing a metallic or unpleasant taste.

Q: Is the effect of Profusol different for men and women?

A: Regulatory information indicates that no sex-specific differentiation in dosing is formally recommended for Profusol.

While some studies have examined the issue, overall, no clear differences in the analgesic response have been consistently documented between men and women.

How should Profusol be stored and disposed of?

How to Store and Dispose of Profusol

Storage of Profusol (Ibuprofen) must adhere to Controlled Room Temperature requirements, specifically between 20 C and 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medication must be protected from freezing and stored in a tight container. Liquid suspensions require shaking well before use.

Official Handling and Disposal

Profusol must be stored out of the sight and reach of children.

Unused or expired medicine should be discarded according to the specific disposal instructions on the product labeling. As the product is not on the official flush list, it should typically be disposed of in the household trash after being mixed with an unpalatable substance to prevent accidental ingestion, following precautionary steps.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Profusol found in:

A-Z Index: